James Watters

Title: James Watters: Innovator in Growth Factor Signaling Pathways

Introduction

James Watters is a notable inventor based in Chalfont, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of growth factor signaling pathways. His work has implications for cancer therapies and personalized medicine.

Latest Patents

Watters holds a patent titled "Methods and gene expression signature for assessing growth factor signaling pathway regulation status." This patent discloses methods, biomarkers, and expression signatures for assessing the regulation status of growth factor pathway signaling in a cell sample or subject. The invention provides a set of genes that can be used as biomarkers and gene signatures for evaluating growth factor pathway deregulation status. It also includes methods for classifying a cell sample as having a deregulated or regulated growth factor signaling pathway, determining whether an agent modulates the growth factor signaling pathway, and predicting the response of a subject to such agents.

Career Highlights

James Watters is currently employed at Merck Sharp & Dohme Corp., where he continues to advance research in his field. His innovative work has led to a deeper understanding of how growth factor pathways can be regulated, which is crucial for developing effective cancer treatments.

Collaborations

Watters has collaborated with notable colleagues, including Andrey Loboda and Michael V Nebozhyn. These collaborations have further enriched his research and contributed to the advancement of knowledge in growth factor signaling.

Conclusion

James Watters is a prominent inventor whose work on growth factor signaling pathways has the potential to transform cancer treatment strategies. His contributions to biotechnology are invaluable and continue to influence the field significantly.